176 related articles for article (PubMed ID: 23405232)
41. Murine CD4+ and CD8+ T cells are activated by the superantigen (SA) staphylococcal enterotoxin B (SEB) and exhibit MHC-unrestricted cytotoxicity.
Miethke T; Bendigs S; Bader P; Wagner H; Heeg K
Zentralbl Bakteriol; 1991 Jun; 275(2):264-8. PubMed ID: 1681814
[TBL] [Abstract][Full Text] [Related]
42. MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.
Radons J; Burkart V; Kolb H
Diabetes; 1997 Mar; 46(3):379-85. PubMed ID: 9032092
[TBL] [Abstract][Full Text] [Related]
43. Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
Perabo FG; Willert PL; Wirger A; Schmidt DH; Von Ruecker A; Mueller SC
Anticancer Res; 2005; 25(5):3565-73. PubMed ID: 16101181
[TBL] [Abstract][Full Text] [Related]
44. Toxicity of the staphylococcal enterotoxin B mutants with histidine-to-tyrosine substitutions.
Korolev S; Pinelis D; Savransky V; Komisar J; Vogel P; Fegeding K
Toxicology; 2003 May; 187(2-3):229-38. PubMed ID: 12699911
[TBL] [Abstract][Full Text] [Related]
45. Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity.
Noël C; Florquin S; Goldman M; Braun MY
Int Immunol; 2001 Apr; 13(4):431-9. PubMed ID: 11282982
[TBL] [Abstract][Full Text] [Related]
46. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
[TBL] [Abstract][Full Text] [Related]
47. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.
Woody MA; Krakauer T; Ulrich RG; Stiles BG
J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976
[TBL] [Abstract][Full Text] [Related]
48. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
49. Production of tumor necrosis factor alpha in human T lymphocytes by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C.
Yan Z; Yang DC; Neill R; Jett M
Infect Immun; 1999 Dec; 67(12):6611-8. PubMed ID: 10569782
[TBL] [Abstract][Full Text] [Related]
50. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
Schols D; Jones D; Roncarolo MG
J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
[TBL] [Abstract][Full Text] [Related]
51. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
52. Mutations affecting the superantigen activity of staphylococcal enterotoxin B.
Briggs C; Garcia C; Zhang L; Guan L; Gabriel JL; Rogers TJ
Immunology; 1997 Feb; 90(2):169-75. PubMed ID: 9135543
[TBL] [Abstract][Full Text] [Related]
53. Enterotoxins can support CAR T cells against solid tumors.
von Scheidt B; Wang M; Oliver AJ; Chan JD; Jana MK; Ali AI; Clow F; Fraser JD; Quinn KM; Darcy PK; Kershaw MH; Slaney CY
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25229-25235. PubMed ID: 31767744
[TBL] [Abstract][Full Text] [Related]
54. Responsiveness of peripheral blood mononuclear cells from normal and atopic donors to microbial superantigens.
König B; Neuber K; König W
Int Arch Allergy Immunol; 1995 Feb; 106(2):124-33. PubMed ID: 7819740
[TBL] [Abstract][Full Text] [Related]
55. T cell dependent B cell activation occurs during the induction of T cell anergy by staphylococcal enterotoxin B in mice.
Abdul-Majid KB; Abedi-Valurgerdi M
Immunol Invest; 1998; 27(1-2):73-88. PubMed ID: 9561919
[TBL] [Abstract][Full Text] [Related]
56. Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins.
Buelow R; O'Hehir RE; Schreifels R; Kummerehl TJ; Riley G; Lamb JR
J Immunol; 1992 Jan; 148(1):1-6. PubMed ID: 1530792
[TBL] [Abstract][Full Text] [Related]
57. Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicity.
LeClaire RD; Kell W; Bavari S; Smith TJ; Hunt RE
Toxicology; 1996 Jan; 107(1):69-81. PubMed ID: 8597033
[TBL] [Abstract][Full Text] [Related]
58. Structural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding site.
Xia T; Liang S; Wang H; Hu S; Sun Y; Yu X; Han J; Li J; Guo S; Dai J; Lou Z; Guo Y
MAbs; 2014; 6(1):119-29. PubMed ID: 24423621
[TBL] [Abstract][Full Text] [Related]
59. Enterotoxin residues determining T-cell receptor V beta binding specificity.
Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
[TBL] [Abstract][Full Text] [Related]
60. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
Lussow AR; MacDonald HR
Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
